OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PSYN.PSX54

Pakistan Synthetics Ltd

Commodity ChemicalsVerified

Pakistan Synthetics Ltd has a debt-to-equity ratio of 1.06, indicating a moderate reliance on debt financing, and a current ratio of 1.12, suggesting limited short-term liquidity cushion. The company's negative operating cash flow of PKR -1.93 billion and free cash flow of PKR -8.41 million highlight a liquidity challenge, with capital expenditures of PKR -132.28 million further straining cash reserves. The company's profitability metrics are weak, with a return on equity of -0.21% and a return on assets of -0.08%, both significantly below the industry median for commodity chemicals. These figures indicate a failure to generate returns for shareholders or effectively utilize assets. Revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in Pakistan. The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year and no forward-looking guidance provided. Historical revenue of PKR 4.45 billion is flat compared to prior periods, and no clear drivers of future expansion are identified. The risk assessment highlights a medium liquidity risk due to negative net cash after subtracting total debt. While dilution risk is currently low, the company's negative net income of PKR 8.77 million and reliance on debt financing could pressure equity value in the future. Recent filings and transcripts are not available in the provided data, so no specific events can be cited to inform the company's recent performance or strategic direction.

30-day price · PSYN.PSX+31.75 (+52.7%)
Low$58.01High$98.91Close$92.00As of15 May, 00:00 UTC
Profile
CompanyPakistan Synthetics Ltd
TickerPSYN.PSX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Pakistan Synthetics Ltd is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of synthetic products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a high confidence level of 0.92 based on verified market data.

Pakistan Synthetics Ltd has a debt-to-equity ratio of 1.06, indicating a moderate reliance on debt financing, and a current ratio of 1.12, suggesting limited short-term liquidity cushion. The company's negative operating cash flow of PKR -1.93 billion and free cash flow of PKR -8.41 million highlight a liquidity challenge, with capital expenditures of PKR -132.28 million further straining cash reserves. The company's profitability metrics are weak, with a return on equity of -0.21% and a return on assets of -0.08%, both significantly below the industry median for commodity chemicals. These figures indicate a failure to generate returns for shareholders or effectively utilize assets. Revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in Pakistan. The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year and no forward-looking guidance provided. Historical revenue of PKR 4.45 billion is flat compared to prior periods, and no clear drivers of future expansion are identified. The risk assessment highlights a medium liquidity risk due to negative net cash after subtracting total debt. While dilution risk is currently low, the company's negative net income of PKR 8.77 million and reliance on debt financing could pressure equity value in the future. Recent filings and transcripts are not available in the provided data, so no specific events can be cited to inform the company's recent performance or strategic direction.
Key takeaways
  • Pakistan Synthetics Ltd is underperforming in profitability, with negative returns on equity and assets.
  • The company faces liquidity challenges, with negative operating and free cash flows.
  • Revenue is not diversified across segments or geographies, increasing exposure to regional risks.
  • Growth is stagnant, with no clear path to expansion or margin improvement.
  • Debt financing is a key component of the capital structure, but it is not yet a source of dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyPKR
Revenue$4.45B
Gross profit$648.3M
Operating income$546.4M
Net income-$8.8M
R&D
SG&A
D&A
SBC
Operating cash flow-$1.93B
CapEx-$132.3M
Free cash flow-$8.4M
Total assets$11.18B
Total liabilities$6.92B
Total equity$4.26B
Cash & equivalents
Long-term debt$4.51B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$7.25B$1.24B$748.4M$602.3M
FY-3$12.31B$1.73B$986.2M-$304.9M
FY-1$13.80B$1.72B$347.8M$652.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-1
PeriodAssetsEquityCashDebt
FY-4$5.70B$2.34B
FY-3$8.56B$3.11B
FY-1$11.18B$4.26B
PeriodOCFCapExFCFSBC
FY-4$1.01B-$410.0M$602.3M
FY-3$989.0M-$1.42B-$304.9M
FY-1-$1.93B-$132.3M$652.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$4.45B$546.4M-$8.8M-$8.4M
FQ-4$5.65B$435.4M$124.8M$223.9M
FQ-3$4.65B$280.7M$73.9M-$358.2M
FQ-2$2.74B$384.1M$129.8M$118.1M
FQ-1$3.24B$314.8M$89.0M-$340.7M
FQ0$4.66B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$11.18B$4.26B
FQ-4$13.31B$4.55B
FQ-3$11.20B$4.63B
FQ-2$13.52B$4.76B
FQ-1$12.33B$4.85B
FQ0$5.02B
PeriodOCFCapExFCFSBC
FQ-7-$1.93B-$132.3M-$8.4M
FQ-4-$96.1M-$415.9M$223.9M
FQ-3$2.20B-$964.0M-$358.2M
FQ-2-$2.57B-$136.8M$118.1M
FQ-1-$1.34B-$705.8M-$340.7M
FQ0-$1.17B-$1.07B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.26B
Net cash-$4.51B
Current ratio1.1
Debt/Equity1.1
ROA-0.1%
ROE-0.2%
Cash conversion220.4%
CapEx/Revenue-3.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricPSYN.PSXActivity
Op margin12.3%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin-0.2%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin14.6%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-3.0%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity106.0%37.1% medp25 10.3% · p75 82.0%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-09 03:44 UTC#b9d731a0
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 02:15 UTCJob: bb85edd5